Detection of neutral endopeptidase 24.11 (Neprilysin) in human hepatocellular carcinomas by immunocytochemistry

Anticancer Research

Volumn 17, Issue 5 A, 1997, Pages 3233-3238

  Dragovic, Tomislav ^a,b   Sekosan, Marin ^a   Becker, Robert P ^a   Erdös, Ervin G ^a  

^a UNIVERSITY OF ILLINOIS   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

Hepatocellular carcinoma; Human; Immunocytochemistry; Neprilysin

Indexed keywords

MEMBRANE METALLOENDOPEPTIDASE;

ARTICLE; BILE DUCT CARCINOMA; COLON ADENOCARCINOMA; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; LIVER CELL CARCINOMA; MALE; PANCREAS ADENOCARCINOMA; PRIORITY JOURNAL; TUMOR DIFFERENTIATION; YOLK SAC TUMOR;

ADENOCARCINOMA; CARCINOMA, HEPATOCELLULAR; CHOLANGIOCARCINOMA; ENDODERMAL SINUS TUMOR; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER; LIVER NEOPLASMS; MALE; NEPRILYSIN; PANCREATIC NEOPLASMS; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 0030729486     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (57)

1. LeBien TW, McCormack RT: The common acute lymphoblastic leukemia antigen (CD10): Emancipation from a functional enigma. Blood 73: 625-635, 1989.
2. Letarte M, Vera S, Tran R, Addis JBL, Onizuka RJ, Quackenbush EJ, Jongeneel CV, McInnes RR: Common acute lymphocytic leukemia antigen is identical to neutral endopeptidase. J Exp Med 168: 1247-1253, 1988.
3. Erdös EG, Skidgel RA: Neutral endopeptidase 24.11-enkephalinase and related regulators of peptide hormones. FASEB J 3: 145-151, 1989.
4. Turner AJ: Endopeptidase 24.11 and neuropeptide metabolism. In: Neuropeptides and their peptidases (Turner AJ, ed). Chichester. Ellis-Horwood, 1987, pp 183-201.
5. Gafford JT, Skidgel RA, Erdös EG, Hersh LB: Human kidney "enkephalinase" a neutral metalloendopeptidase that cleaves active peptides. Biochemistry 22: 3265-3271, 1983.
6. Olins GM, Krieter PA, Trapani AJ, Spear KL, Bovy PR: Specific inhibitors of endopeptidase 24.11 inhibit the metabolism of atrial natriuretic peptides in vitro and in vivo. Mol Cell Endocrinol 61: 201-208, 1989.
7. Malfroy B, Swerts JP, Llorens C, Schwartz JC: Regional distribut4ion of a high-affinity enkephalin-degrading peptidase "(enkephalinase)" and effects of lesions suggest localization in the vicinity of opiate receptors in brain. Neurosci Lett 11: 329-334, 1979.
8. Schwartz J-C, Malfroy B, De La Baume S: Biological inactivation of enkephalins and the role of enkephalin-dipeptidyl-carboxypeptidase "(enkephalinase)" as neuropeptidase. Life Sci 29: 1715-1740, 1981.
9. Metzgar SR, Borowitz JM, Jones HN, Dowell LB: Distribution of common acute lymphoblastic leukemia antigen in nonhematopoietic tissues. J Exp Med 154: 1249-1254, 1981.
10. Schulz WW, Hagler HK, Buja LM, Erdös EG: Ultrastructural localization of angiotensin 1 converting enzyme (EC 3.4.15.1) and neutral metallo-endopeptidase (EC 3.4.24.11) in the proximal tubule of the human kidney. Lab Invest 59: 789-797, 1988.
11. Erdös EG, Schulz WW, Gafford JT, Defendini R: Neutral mctalloendopeptidase in human male genital tract. Comparison to angiotensin I converting enzyme. Lab Invest 52: 437-447, 1985.
12. Dusser DJ, Nadel JA, Sekizawa K, Graf PD, Borson DB: Neutral endopeptidase and angiotensin converting enzyme inhibitors potentiate kinin-induced contraction of ferret trachea. J Pharmacol Exp Ther 244: 531-536, 1988.
13. Connelly JC, Skidgel RA, Schulz WW, Johnson AR, Erdös EG: Neutral endopeptidase 24.11 in human neutrophils: Cleavage of chemotactic peptide. Proc Natl Acad Sci USA 82: 8737-8741, 1985.
14. Painter RG, Dukes R, Sullivan J, Carter R, Erdös EG, Johnson AR: Function of neutral endopeptidase on the cell membrane of human neutrophils. J Biol Chem 263: 9456-9461, 1988.
15. Johnson AR, Ashton J, Schulz WW, Erdös EG: Neutral metalloendopeptidase in human lung tissue and cultured cells. Am Rev Respir Dis 132: 564-568, 1985.
16. Carrel S, Schmidt-Kessen A, Mach J-P, Heumann D, Girardet C: Expression of common acute lymphoblastic leukemia antigen (CALLA) on human malignant melanoma cell lines. J Immunol 130: 2456-2460, 1983.
17. Kee BL, Dadi HK, Tran-Paterson R, Quackenbush EJ, Andrulis IL, Letarte M: CD10 and CD44 genes of leukemic cells and malignant cell lines show no evidence of transformation-related alterations. J Cell Physiol 148: 414-420, 1991.
18. Mechtersheimer G: Towards the phenotyping of soft tissue tumors by cell surface molecules. Virchows Arch Pathol Anat 419: 7-28, 1991.
19. Shipp MA, Tarr GE, Chen CY, Switzer SN, Hersh LB, Stein H, Sunday ME, Reinherz EL: CD10/neutral endopeptidase 24.11 hydrolyzes bombesin-like peptides and regulates the growth of small cell carcinomas of the lung. Proc Natl Acad Sci USA 88: 10662-10666, 1991.
20. Deddish PA, Dragovic T, Erdös EG, Weber G: High concentration of neutral endopeptidase (enkephalinase E.C. 3.4.24.11) in malignant tumor: Rat hepatoma 3924A. Biochem Biophys Res Commun 169: 81-86, 1990.
21. Dragovic T, Deddish PA, Tan F, Weber G, Erdös EG: Increased expression of neprilysin (neutral endopeptidase 24.11) in rat and human hepatocellular carcinomas. Lab Invest 70: 107-113, 1994.
22. Nadji M, Morales AR: Immunoperoxidase techniques: a practical approach to tumor diagnosis. Chicago, Am Soc of Clin Pathol Press, 1986, pp 25-27.
23. Nagae A, Deddish PA, Becker RP, Anderson CH, Abe M, Tan F, Skidgel RA, Erdös EG: Carboxypeptidase M in brain and peripheral nerves. J Neurochem 59: 2201-2212, 1992.
24. Nagae A, Abe M, Becker RP, Deddish PA, Skidgel RA, Erdös EG: High concentration of carboxypeptidase M in lungs: Presence of the enzyme in alveolar type I cells. Am J Respir Cell Mol Biol 9: 221-229, 1993.
25. Beasley PR: Hepatitis B virus. The major etiology of hepatocellular carcinoma. Cancer 61: 1942-1956, 1988.
26. London TW: Primary hepatocellular carcinoma-etiology, pathogenesis and prevention. Hum Pathol 12: 1085-1097, 1981.
27. Ekelund P, Wasastjerna C: Cytologic identification of primary hepatic carcinoma cells. Acta Med Scand 189: 373-375, 1971.
28. Ganjei P, Nadji M, Saavedra AJ, Morales RA: Histologic markers in primary and metastatic tumors of the liver. Cancer 62: 1994-1998, 1988.
29. Ma KC, Zarbo JR, Frierson FH, Lee WM: Comparative immunohistocytochemical study of primary and metastatic carcinomas of the liver. Am J Clin Pathol 99: 551-557, 1993
30. Wang AM, Yazdi MH: Hepatocellular carcinoma versus carcinoma metastatic to the liver. Value of stains for carcinoembriogenic antigen and naphthylamidase in fine needle aspiration biopsy material. Acta Cytol 34: 192-196, 1990.
31. Palmer PE, Wolfe HJ: Immunocytochemical localization of oncofetal proteins in human germ cell and hepatic tumors. J Histochem Cytochem 20: 523-531, 1978.
32. Thung NS, Gerber AM, Savno E, Popper H: Distribution of five antigens in hepatocellular carcinoma. Lab Invest 41: 101-105, 1979.
33. Thung NS, Gerber AM, Savno E, Popper H: Hepatocellular cancer: Differences between high and low incidence regions. Lancet Nov 21: 1183-1185, 1987.
34. Brumm C, Schulze C, Charles K, Marahashi T, Klopell G: The significance of alpha-tetoprotein and other tumor markers in differential immunocytochemistry of primary liver tumors. Histopathology 14: 503-513, 1989.
35. Espinoza GC, Pillarisetti GS, Azar AH: Immunocytochemistry of hepatocellular carcinoma associated with cirrhosis. Ann Clin Lab Sci 14: 467-473, 1984.
36. Goodman DZ, Ishak GK, Langloss MJ, Sesterhenn, Rabin L: Combined hepatocellular-cholangiocarcinoma. A histologic immunocytochemical study. Cancer 55: 124-135, 1985.
37. Izguierdo FA, Bosch LA: Immunocytochemical characterization of 130 cases of primary hepatic carcinomas. Path Res Pract 182: 783-791, 1987.
38. DuBoulay CEH: Demonstration of alpha-1-antitrypsin and alpha-1-antichymotrypsin in fibrous hystiocitoma using the immunoperoxidase technique. Am J Surg Pathol 6: 559-564, 1982.
39. Cohen C, Berson SD, Budgeon LR: Alpha-1-antitrypsin deficiency in Southern African hepatocellular carcinoma patients. An immunoperoxidase and histochemical study. Cancer 49: 2537-2540, 1982.
40. Koelma IA, Nap M, Huitema S, Krom RAF, Houthotf HJ: Hepatocellular carcinoma, adenoma and focal nodular hyperplasia. Arch Pathol Lab Med 110: 1035-1040, 1986.
41. Cooper D, Scherman A, Sun TT: Classification of human epithelia and their neoplasms using monoclonal antibodies to keratins: Strategies, applications and limitations. Lab Invest 52: 243-256, 1985.
42. Fisher PH, Altmannsberger M, Weber K, Osborn M: Keratin polypeptides in malignant epithelial liver tumors. Am J Pathol 127: 530-537, 1987.
43. Johnson ED, Herndier GB, Medeiros LJ, Warnke AR, Rouse UR: The diagnostic utility of the keratin profiles of hepatocellular carcinoma and cholangiocarcinoma. Am J Surg Pathol 12: 187-197, 1988.
44. Van Eyken P, Sciot R, Paterson A, Callea F, Kew CM, Desmet JV: Cytokeratin expression in hepatocellular carcinoma. An immunocytochemical study. Hum Pathol 19: 562-568, 1988.
45. Maeda T, Kajiyama K, Adachi E, Takenaka K, Sugimuchi K, Tsuneyoshi M: The expression of cytokeratin 7, 19, and 20 in primary and metastatic carcinoma of the liver. Mod Pathol 9: 901-909, 1996.
46. Torii A, Nakayama A, Harada A, Nakao A, Nonami T, Sakamoto J. Watanahe T, Ito M, Takagi H: Expression of the CD15 antigen in hepatocellular carcinoma. Cancer 71: 3804-3867, 1993.
47. Soulier JP, Gozin D, Lefrere JJ: A new method to assay descarboxyprothrombin. Results obtained in 75 cases of hepatocellular carcinoma. Gastroenterology 91: 1258-1262, 1986.
48. Wasastjema C: A cytochemical method for study of bile canaliculi in five needle aspirates from liver. Acta Pathol Microbiol Scand 77: 399-404, 1969.
49. Nadji M, Matsuko S, Ganjei P, Weissman ZJ, Penneys SM: Monoclonal antibody ERY-1 identifies an antigen in erythroid cells, hepatocellular and renal cell carcinoma. Acta Haemat 79: 68-71, 1988.
50. Yoshida K, Tadaoka Y, Manabe T: Expression of lammin in hepatocellular carcinoma: An adjunct for its histologic diagnosis. Jpn J Clin Oncol 26: 70-6, 1996.
51. Guindi M, Yazdi HM, Gillatt MA: Fine needle aspiration of hepatocellular carcinoma. Value of imrnunohistochemical and ultrastructural studies. Acta Cytol 38: 385-391, 1994.
52. Fucich LF, Cheles MK, Thung SN, Gerber MA, Marrogi AJ: Primary vs. metastatic hepatic carcinoma. An immunohistochemical study of 34 cases. Arch Pathol Lab Med 118: 927-30, 1994.
53. Greaves MF, Brown G, Rapson NT, Listert A: Antisera to acute lymphoblastic leukemia cells. Clin Immunol Immunopathol 4: 67-84, 1975.
54. Paterson TR, Boileaux G, Giguere U, Letarte M: Comparative levels of CALLA/neutral endopeptidase on nommal granulocytes, leukemic cells and transfected COS-1 cells. Blood 76: 775-782, 1990.
55. Bond JS, Barrett AJ: Proteolysis and Protein Turnover. Proceedings of the 9th ICOP Meeting, Williamsburg, Virginia, USA. London, Portland Press, 1993, pp 1-261.
56. Patel KV, Schrey MP: Inhibition of DNA synthesis and growth in human breast stromal cells by bradykinin: evidence for independent roles of B 1 and B2 receptors in the respective control of cell growth and phospholipid hydrolysis. Cancer Res 52: 334-340, 1992.
57. Elliott PJ, Hayward NJ, Dean RL, Blunt DG, Bartus RT: Intravenous RMP-7 selectively increases uptake of carboplatin into rat brain tumors. Cancer Res 56: 3998-4005, 1996.